Astigmatism in cataract patients

Article

Most candidates for cataract surgery have a degree of corneal astigmatism, which should be considered by intraocular lens (IOL) manufacturers, concluded a study published in the January issue of the Journal of Cataract & Refractive Surgery.

Most candidates for cataract surgery have a degree of corneal astigmatism, which should be considered by intraocular lens (IOL) manufacturers, concluded a study published in the January issue of the Journal of Cataract & Refractive Surgery.

Teresa Ferrer-Blasco, PhD of the University of Valencia, Spain and colleagues gathered preoperative measurements of the refractive and keratometric values of eyes undergoing cataract extraction (n=4540).

The team found that older eyes had a tendency towards less negative corneal astigmatism. Only 13.2% of eyes demonstrated no corneal astigmatism: astigmatism of 0.25–1.25 diopters was present in 64.4% of eyes, and of ≥1.5 D in 22.2% of eyes.

The team concluded that, although the values differed slightly between age groups, corneal astigmatism was present in the majority of cataract surgery candidates, although to a degree of greater than 1.5 D in only approximately one fifth of cases. The researchers recommended that IOL manufacturers and cataract surgeons should consider this information when evaluating the appropriate IOLs for patients.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.